Expression of cholinesterases in human kidney and its variation in renal cell carcinoma types

FEBS Journal

Volumn 277, Issue 21, 2010, Pages 4519-4529

  Muñoz Delgado, Encarnación ^a   Montenegro, María Fernanda ^a   Campoy, Francisco Javier ^a   Moral Naranjo, María Teresa ^a   Cabezas Herrera, Juan ^b   Kovacs, Gyula ^c   Vidal, Cecilio J ^a  

^a UNIVERSITY OF MURCIA   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Chromophobe renal cell carcinoma (chRCC); Conventional renal cell carcinoma (cRCC); Glycosylphosphatidylinositol anchor; Papillary renal cell carcinoma (pRCC); Renal oncocytoma

Indexed keywords

ACETYLCHOLINESTERASE; CHOLINESTERASE; GLYCOSYLPHOSPHATIDYLINOSITOL; MESSENGER RNA; LECTIN;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INDUCTION; ENZYME SYNTHESIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY; KIDNEY CARCINOMA; NEPHRECTOMY; ONCOCYTOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEDIMENTATION; BLOOD; ENZYMOLOGY; ERYTHROCYTE; GENE EXPRESSION REGULATION; GENETICS; KIDNEY TUMOR; METABOLISM; PATHOLOGY; PROTEIN BINDING;

ACETYLCHOLINESTERASE; BUTYRYLCHOLINESTERASE; CARCINOMA, RENAL CELL; CHOLINESTERASES; ERYTHROCYTES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KIDNEY; KIDNEY NEOPLASMS; LECTINS; PROTEIN BINDING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 79952112589     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2010.07861.x     Document Type: Article

References (55)

1. Jemal A, Siegel R, Ward E, Hao X, Xu J & Thun MJ (2009) Cancer statistics. CA Cancer J Clin 59, 225-249.
2. Kovacs G, Akhtar M, Beckwith BJ, Bugert P, Cooper CS, Delahunt B, Eble JN, Fleming S, Ljungberg B, Medeiros LJ et al. (1997) The Heidelberg classification of renal cell tumours. J Pathol 183, 131-133.
3. Moch H, Gasser T, Amin MB, Torhorst J, Sauter G & Mihatsch MJ (2000) Prognostic utility of the recently recommended histologic classification and revised TNM staging system of renal cell carcinoma. A Swiss experience with 588 tumors. Cancer 89, 604-614. (Pubitemid 30640107)
4. Hansel DE (2006) Genetic alterations and histopathologic findings in familial renal carcinoma. Histol Histopathol 21, 437-444.
5. Kovacs G, Fuzesi L, Emanual A & Kung HF (1991) Cytogenetics of papillary renal cell tumors. Genes Chromosomes Cancer 3, 249-255.
6. Brunelli M, Eble JN, Zhang S, Martignoni G, Delahunt B & Cheng L (2004) Eosinophilic and classic chromophobe renal cell carcinomas have similar frequent losses of multiple chromosomes from among chromosomes 1, 2, 6, 10, and 17, and this pattern of genetic abnormality is not present in renal oncocytoma. Mod Pathol 18, 161-169.
7. Zubakov D, Stupar Z & Kovacs G (2006) Differential expression of a new isoform of DLG2 in renal oncocytoma. BMC Cancer 6, 106. doi:10.1186/1471- 2407-6-106.
8. Linehan WM, Bratslavsky G, Pinto PA, Schmidt LS, Neckers L, Bottaro DP & Srinivasan R (2010) Molecular diagnosis and therapy of kidney cancer. Annu Rev Med 61, 329-343.
9. Getman DK, Eubanks JH, Camp S, Evans GA & Taylor P (1992) The human gene encoding AChE is located on the long arm of chromosome 7. Am J Hum Genet 51, 170-177.
10. Allderdice PW, Gardner HA, Galutira D, Lockridge O, La Du BN & McAlpine PJ (1991) The cloned butyrylcholinesterase (BCHE) gene maps to a single chromosome site, 3q26. Genomics 11, 452-454.
11. Meshorer E & Soreq H (2006) Virtues and woes of AChE alternative splicing in stress-related neuropathologies. Trends Neurosci 29, 216-224.
12. Fernández-Gómez FJ, Muñoz-Delgado E, Montenegro MF, Campoy FJ, Vidal CJ & Jordán J (2010) Cholinesterase activity in brain of senescence-accelerated-resistant mouse SAMR1 and its variation in brain of senescence-accelerated-prone mouse SAMP8. J Neurosci Res 88, 155-166.
13. Massoulié J, Perrier N, Noureddine H, Liang D & Bon S (2008) Old and new questions about cholinesterases. Chem Biol Interact 175, 30-44.
14. Nieto-Cerón S, Sánchez del Campo LF, Muñoz-Delgado E, Vidal CJ & Campoy FJ (2005) Muscular dystrophy by merosin deficiency decreases acetylcholinesterase activity in thymus of Lama2dy mice. J Neurochem 95, 1035-1046. (Pubitemid 41713488)
15. Altamirano CV & Lockridge O (1999) Conserved aromatic residues of the C-terminus of human butyrylcholinesterase mediate the association of tetramers. Biochemistry 38, 13414-13422.
16. Mack A & Robitzki A (2000) The key role of butyrylcholinesterase during neurogenesis and neural disorders: an antisense- 5′butyrylcholinesterase-DNA study. Prog Neurobiol 60, 607-628. (Pubitemid 30100400)
17. Paraoanu LE, Steinert G, Koehler A, Wessler I & Layer PG (2007) Expression and possible functions of the cholinergic system in a murine embryonic stem cell line. Life Sci 80, 2375-2379. (Pubitemid 46818286)
18. Johnson G, Swart C & Moore SW (2008) Non-enzymatic developmental functions of acetylcholinesterase - the question of redundancy. FEBS J 275, 5129-5138.
19. Greenfield S, Zimmermann M & Bond CE (2008) Non-hydrolytic functions of acetylcholinesterase. The significance of C-terminal peptide. FEBS J 275, 604-611.
20. Silveyra MX, Evin G, Montenegro MF, Vidal CJ, Martínez S, Culvenor JG & Sáez-Valero J (2008) Presenilin-1 interacts with acetylcholinesterase and alters its enzymatic activity and glycosylation. Mol Cell Biol 28, 2908-2919. (Pubitemid 351556524)
21. Mor I, Bruck T, Greenberg D, Berson A, Schreiber L, Grisaru D & Soreq H (2008) Alternate AChE-R variants facilitate cellular metabolic activity and resistance to genotoxic stress through enolase and RACK1 interactions. Chem Biol Interact 175, 11-21.
22. Perry C, Pick M, Podoly E, Gilboa-Geffen A, Zimmerman G, Sklan EH, Ben-Shaul Y, Diamant S & Soreq H (2007) Acetylcholinesterase/C terminal binding protein interactions modify Ikaros functions, causing T lymphopenia. Leukemia 21, 1472-1480. (Pubitemid 46965289)
23. Gong X, Ye W, Zhou H, Ren X, Zhigang L, Zhou W, Wu J, Gong Y, Ouyang Q, Zhao X et al. (2009) Ran-BPM is an acetylcholinesterase-interacting protein that translocates into the nucleus during apoptosis. Acta Biochim Biophys Sin 41, 883-891.
24. Darreh-Shori T, Modiri N, Blennow K, Baza S, Kamil C, Ahmed H, Andreasen N & Nordberg A (2010) The apolipoprotein E varepsilon4 allele plays pathological roles in AD through high protein expression and interaction with butyrylcholinesterase. Neurobiol Aging doi:10.1016/j.neurobiolaging.2009.07.015.
25. Darreh-Shori T, Forsberg A, Modiri N, Andreasen N, Blennow K, Kamil C, Ahmed H, Almkvist O, Lanströng B & Nordberg A (2010) Differential levels of apolipoprotein E and butyrylcholinesterase show strong association with pathological signs of Alzheimer's disease in the brain in vivo. Neurobiol Aging doi:10.1016/j.neurobiolaging.2010.04.028.
26. Vidal CJ (2005) Expression of cholinesterases in brain and non-brain tumours. Chem Biol Interact 157-158, 227-232.
27. Perry C, Sklan EH, Birikh K, Shapira M, Trejo L, Eldor A & Soreq H (2002) Complex regulation of acetylcholinesterase gene expression in human brain tumors. Oncogene 21, 8428-8441. (Pubitemid 36054884)
28. Calaf GM, Parra E & Garrido F (2007) Cell proliferation and tumor formation induced by eserine, an acetylcholinesterase inhibitor, in rat mammary gland. Oncol Rep 17, 25-33.
29. Ruiz-Espejo F, Cabezas-Herrera J, Illana J, Campoy FJ, Muñoz-Delgado E & Vidal CJ (2003) Breast cancer metastasis alters acetylcholinesterase activity and the composition of enzyme forms in axillary lymph nodes. Breast Cancer Res Treat 80, 105-114. (Pubitemid 36851290)
30. Montenegro MF, Ruiz-Espejo F, Campoy FJ, Muñoz-Delgado E, Páez de la Cadena M, Rodríguez-Berrocal FJ & Vidal CJ (2006) Cholinesterases are down-expressed in human colorectal carcinoma. Cell Mol Life Sci 63, 2175-2182. (Pubitemid 44465690)
31. Martínez-Moreno P, Nieto-Cerón S, Torres-Lanzas J, Ruiz-Espejo F, Tovar-Zapata I, Martínez-Hernández P, Rodríguez-López JN, Vidal CJ & Cabezas-Herrera J (2006) Cholinesterase activity of human lung tumours varies according to their histological classification. Carcinogenesis 27, 429-436. (Pubitemid 43372872)
32. Suda A (1986) A histochemical localization of acetylcholinesterase and cholinesterase activities in mammalian kidneys. Acta Histochem 79, 107-114.
33. Veronesi B (1996) Characterization of the MDCK cell line for screening neurotoxicants. Neurotoxicology 17, 433-443.
34. Wessler I & Kirkpatrick CJ (2008) Acetylcholine beyond neurons: the non-neuronal cholinergic system in humans. Br J Pharmacol 154, 1558-1571.
35. García-Ayllón MS, Sáez-Valero J, Piqueras-López C & Vidal CJ (1999) Characterization of molecular forms of acetyl- and butyrylcholinesterase in human acoustic neurinomas. Neurosci Lett 274, 56-60.
36. Ruiz-Espejo F, Cabezas-Herrera J, Illana J, Campoy FJ & Vidal CJ (2002) Cholinesterase activity and acetylcholinesterase glycosylation are altered in human breast cancer. Breast Cancer Res Treat 72, 11-22. (Pubitemid 34274311)
37. Sáez-Valero J & Vidal CJ (1996) Biochemical properties of acetyl- and butyrylcholinesterase in human meningioma. Biochim Biophys Acta 1317, 210-218. (Pubitemid 26426549)
38. Gómez JL, Nieto-Cerón S, Campoy FJ, Muñoz-Delgado E & Vidal CJ (2003) Purification and properties of hydrophilic dimers of acetylcholinesterase from mouse erythrocytes. Int J Biochem Cell Biol 35, 1109-1118. (Pubitemid 36369498)
39. Martínez-López de Castro A, Nieto-Cerón S, Pons-Castillo A, Galvis-Martínez L, Latour-Pérez J, Torres-Lanzas J, Tovar-Zapata I, Martínez-Hernández P, Rodríguez- López JN & Cabezas-Herrera J (2008) Cancer-associated differences in acetylcholinesterase activity in bronchial aspirates from patients with lung cancer. Clin Sci 115, 245-253.
40. Lockridge O (1990) Genetic variants of human serum cholinesterase influence metabolism of the muscle relaxant succinylcholine. Pharmacol Ther 47, 35-60.
41. Luppa H, Alabdalla M, Andrä J & Weiss J (1992) Histochemical investigations on the localization of acetylcholinesterase in the kidney of selected vertebrates. Acta Histochem 92, 147-159.
42. Toiber D, Berson A, Greenberg D, Melamed-Book N, Diamant S & Soreq H (2008) N-Acetylcholinesterase-induced apoptosis in Alzheimer's disease. PLoS ONE 3, 1-12.
43. Moral-Naranjo MT, Montenegro MF, Muñoz-Delgado E, Campoy FJ & Vidal CJ (2010) The level of both lipid rafts and raft-located acetylcholinesterase dimers increase in muscle of mice with muscular dystrophy by merosin deficiency. Biochim Biophys Acta Mol Basis Dis 1802, 754-764.
44. Shaked I, Meerson A, Wolf Y, Avni R, Greenberg D, Gilboa-Geffen A & Soreq H (2009) MicroRNA-132 potentiates cholinergic anti-inflammatory signaling by targeting acetylcholinesterase. Immunity 31, 965-973.
45. Motamed-Khorasani A, Jurisica I, Letarte M, Shaw PA, Parkes RK, Zhang X, Evangelou A, Rosen B, Murphy KJ & Brown TJ (2007) Differentially androgen-modulated genes in ovarian epithelial cells from BRCA mutation carriers and control patients predict ovarian cancer survival and disease progression. Oncogene 26, 198-214. (Pubitemid 46095731)
46. Soreq L, Gilboa-Geffen A, Berrih-Aknin S, Lacoste P, Darvasi A, Soreq E, Bergman H & Soreq H (2008) Identifying alternative hyper-splicing signatures in MG-thymoma by exon arrays. PLoS ONE 3, 1-18.
47. Jiang H & Zhang XJ (2008) Acetylcholinesterase and apoptosis. A novel perspective for an old enzyme. FEBS J 275, 612-617.
48. Rázc A, Brass N, Heckel D, Pahl S, Remberger K & Meese E (1999) Expresion analysis of genes at 3q26-q27 involved in frequent amplification in squamous cell lung carcinoma. Eur J Cancer 35, 641-646. (Pubitemid 29192975)
49. Grigoriadis A, Mackay A, Reis-Filho JS, Steele D, Iseli C, Stevenson BJ, Jongeneel CV, Valgeirsson H, Fenwick K, Iravani M et al. (2006) Establishment of the epithelial-specific transcriptome of normal and malignant human breast cells based on MPSS and array expression data. Breast Cancer Res 8, R56. doi: 10.1186/bcr1604.
50. Kobayashi T, Kubota K, Sudo K, Mori M, Sano K, Yotsuyanagi H & Makuuchi M (1999) Cholinesterase-producing hepatocellular carcinoma. J Hepatol 30, 348-349.
51. Hamamoto Y, Niino K, Ishiyama H & Hosoya T (2004) Impact of pretreatment cholinesterase level on survival of inoperable intrahepatic or hepatic-hilar carcinoma treated with three-dimensional conformal radiotherapy. Rad Med 22, 316-323. (Pubitemid 39469709)
52. Layer PG, Allebrandt K, Andermann P, Bodur E, Boopathy R, Bytyqi AH & Paraoanu LE (2005) On the multifunctionality of cholinesterases. Chem Biol Interact 157-158, 37-41. (Pubitemid 41757631)
53. Kamal MA, Nasim FH & Al-Jafari AA (1999) Human erythrocyte acetylcholinesterase inhibition by cis-diamminediaquaplatinum (II): a novel kinetic approach. Cancer Lett 138, 115-119. (Pubitemid 29189193)
54. Rosner I, Bratslavsky G, Pinto PA & Linehan WM (2009) The clinical implications of the genetics of renal cell carcinoma. Urol Oncol 27, 131-136.
55. Yeboah MM, Xue X, Javdan M, Susin M & Metz CN (2008) Nicotinic acetylcholine receptor expression and regulation in the rat kidney after ischemia-reperfusion injury. Am J Physiol 295, F654-F661.